AIDS

1. COLBRUNN DK, Jacks C, Curry SR, Gebregziabher M, et al
   Outcomes of discordant HIV screening test results at a southern academic medical center.
   AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003884.
   

   >> Share

   
   
2. CROWELL TA, Ritz J, Zheng L, Naqvi A, et al
   Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
   AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003881.
   

   >> Share

   
   
3. FILIP I
   Changing costs of pre-exposure prophylaxis may undermine efforts to curb HIV infection rates.
   AIDS. 2024 Mar 12. doi: 10.1097/QAD.0000000000003883.
   

   >> Share

   
   
4. 
   Prevalence and incidence of stroke among people with HIV: Erratum.
   AIDS. 2024;38:777.
   

   >> Share

   
   
5. DE COCK KM, El-Sadr WM
   Authors' response to comment on 'Invisible, but not absent'.
   AIDS. 2024;38:774-775.
   

   >> Share

   
   
6. AMON JJ
   To end AIDS, human rights must remain at the center of the HIV response.
   AIDS. 2024;38:773-774.
   

   >> Share

   
   
7. FRESSE A, Massy N, Fournier D, Pinel S, et al
   Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.
   AIDS. 2024;38:768-771.
   

   >> Share

   
   
8. FRASER D, Holt M, Ong JJ, Bourne C, et al
   A proposal for a simplified measure of HIV preexposure prophylaxis prevention-effective adherence in self-report questionnaires.
   AIDS. 2024;38:765-767.
   

   >> Share

   
   
9. GONZALEZ-SCARANO F, Napravnik S, Vance DE
   Frailty and HIV-associated neurocognitive disorder are only modestly associated.
   AIDS. 2024;38:757-759.
   

   >> Share

   
   
10. GOODREAU SM, Wohlfeiler DA, Bertrand T
    Bringing back condoms.
    AIDS. 2024;38:761-763.
    

    >> Share

    
    
11. WILKINSON L, Grimsrud A
    Enabling effective differentiated service delivery transitions for people on antiretroviral treatment.
    AIDS. 2024;38:615-622.
    

    >> Share

    
    

    
    AIDS Res Hum Retroviruses

12. WOHLFEILER MB, Weber RP, Brunet L, Siddiqui J, et al
    Incident HIV-Associated Wasting/Low Weight is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
    AIDS Res Hum Retroviruses. 2024 Mar 14. doi: 10.1089/AID.2023.0113.
    

    >> Share

    
    
13. FOLGOSI VA, Konminakis SV, Silva FDD, Leite Junior PD, et al
    Evaluation of the New Multi-HTLV Serological Assay: Improvement for HTLV-2 Detection.
    AIDS Res Hum Retroviruses. 2024;40:134-140.
    

    >> Share

    
    
14. FAJAMI Z, Akbarin MM, Rafatpanah H, Ramezani S, et al
    Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients.
    AIDS Res Hum Retroviruses. 2024;40:141-147.
    

    >> Share

    
    

    
    Antimicrob Agents Chemother

15. WANG C, Yu X, Ke Y, Fu Y, et al
    Efficacy and effect on lipid profiles of switching to ainuovirine-based regimen versus continuing efavirenz-based regimen in people with HIV-1: 24-week results from a real-world, retrospective, multi-center cohort study.
    Antimicrob Agents Chemother. 2024 Mar 14:e0166823. doi: 10.1128/aac.01668.
    

    >> Share

    
    

    
    BMJ

16. DYER O
    Surge in anti-gay laws in Africa imperil progress on HIV/AIDS, experts say.
    BMJ. 2024;384:q599.
    

    >> Share

    
    

    
    Clin Infect Dis

17. LANDOVITZ RJ, Tao L, Yang J, de Boer M, et al
    HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies.
    Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093.
    

    >> Share

    
    
18. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2024 Mar 11:ciae126. doi: 10.1093.
    

    >> Share

    
    
19. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
    Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
    Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

20. VIOLETTE LR, Thomas KK, Dorward J, Quame-Amaglo J, et al
    Early HIV viral suppression associated with subsequent 12-month treatment success among people living with HIV in South Africa.
    HIV Med. 2024 Mar 15. doi: 10.1111/hiv.13633.
    

    >> Share

    
    
21. ZHAO J, Zhang L, Li L, Xie X, et al
    Growth of infants delivered by mothers with HIV in Guangxi, China: An 18-month longitudinal follow-up study, 2015-2021.
    HIV Med. 2024 Mar 13. doi: 10.1111/hiv.13624.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

22. WEISER J, Tie Y, Crim SM, Riedel DJ, et al
    Do HIV Care Outcomes Differ by Provider Type?
    J Acquir Immune Defic Syndr. 2024 Mar 7. doi: 10.1097/QAI.0000000000003410.
    

    >> Share

    
    
23. NUNEZ I, Ceballos-Liceaga SE, Torre A, Garcia-Rodriguez G, et al
    Clinical features and outcomes of mpox in people with and without HIV: a national comparative study.
    J Acquir Immune Defic Syndr. 2024 Mar 4. doi: 10.1097/QAI.0000000000003407.
    

    >> Share

    
    
24. MADLALA HP, Myer L, Geffen H, Rusch J, et al
    Inflammatory markers in pregnancy are associated with postpartum weight in South African women living with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2024 Mar 4. doi: 10.1097/QAI.0000000000003406.
    

    >> Share

    
    
25. MOAWAD MHED, Mohamed Shalaby MM, Hamouda E, Mahfouz A, et al
    Risk of Stroke Among HIV Patients: A Systematic Review and Meta-analysis of Global Studies and Associated Comorbidities.
    J Acquir Immune Defic Syndr. 2024;95:399-410.
    

    >> Share

    
    
26. FU W, McClymont E, Av-Gay G, Dorling M, et al
    Retrospective Cohort Study on the Impact of the COVID-19 Pandemic on Pregnancy Outcomes for Women Living With HIV in British Columbia.
    J Acquir Immune Defic Syndr. 2024;95:411-416.
    

    >> Share

    
    
27. SHADE SB, Gutin SA, Agnew E, Grignon JS, et al
    Cost Analysis of Short Messaging Service and Peer Navigator Interventions for Linking and Retaining Adults Recently Diagnosed With HIV in Care in South Africa.
    J Acquir Immune Defic Syndr. 2024;95:417-423.
    

    >> Share

    
    
28. YOUNGUI BT, Atwine D, Otai D, Vasiliu A, et al
    Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda.
    J Acquir Immune Defic Syndr. 2024;95:431-438.
    

    >> Share

    
    
29. KABAMI J, Koss CA, Sunday H, Biira E, et al
    Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya.
    J Acquir Immune Defic Syndr. 2024;95:447-455.
    

    >> Share

    
    
30. DORWARD J, Sookrajh Y, Lessells R, Bulo E, et al
    Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2024;95:e8-e11.
    

    >> Share

    
    

    
    J Clin Invest

31. ELIZALDI SR, Hawes CE, Verma A, Shaan Lakshmanappa Y, et al
    Chronic SIV-induced neuroinflammation disrupts CCR7+CD4+ T cell immunosurveillance in the rhesus macaque brain.
    J Clin Invest. 2024 Mar 12:e175332. doi: 10.1172/JCI175332.
    

    >> Share

    
    

    
    J Infect Dis

32. GRUNER E, Grossegesse M, Stern D, Ober V, et al
    Mpox-specific immune responses elicited by vaccination or infection in people living with HIV.
    J Infect Dis. 2024 Mar 13:jiae138. doi: 10.1093.
    

    >> Share

    
    
33. BURDORF R, Zhou S, Amon C, Long N, et al
    Impact Of Low-Frequency HIV-1 Drug Resistance Mutations On Antiretroviral Therapy Outcomes.
    J Infect Dis. 2024 Mar 11:jiae131. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

34. CORMA-GOMEZ A, Cabello A, Orviz E, Morante-Ruiz M, et al
    Long or complicated mpox in patients with uncontrolled HIV infection.
    J Med Virol. 2024;96:e29511.
    

    >> Share

    
    

    
    Lancet

35. KANKASA C, Mennecier A, Sakana BLD, Moles JP, et al
    Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
    Lancet. 2024 Mar 11:S0140-6736(23)02464-9. doi: 10.1016/S0140-6736(23)02464.
    

    >> Share

    
    
36. MUTALE W, Herce ME
    Closing the gap in paediatric HIV infections: how available tools and technology can accelerate progress towards ending AIDS by 2030.
    Lancet. 2024 Mar 11:S0140-6736(24)00366-0. doi: 10.1016/S0140-6736(24)00366.
    

    >> Share

    
    
37. 
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    

    >> Share

    
    

    
    Lancet Infect Dis

38. COHN J, Mendelson M, Kanj SS, Shafiq N, et al
    Accelerating antibiotic access and stewardship: a new model to safeguard public health.
    Lancet Infect Dis. 2024 Mar 11:S1473-3099(24)00070.
    

    >> Share

    
    

    
    Nat Rev Immunol

39. FLEMMING A
    CARD8 kills CD4(+) T cells in response to HIV entry.
    Nat Rev Immunol. 2024 Mar 11. doi: 10.1038/s41577-024-01021.
    

    >> Share

    
    

    
    Nature

40. LENHARO M
    Blockbuster obesity drug leads to better health in people with HIV.
    Nature. 2024 Mar 11. doi: 10.1038/d41586-024-00691.
    

    >> Share

    
    

    
    PLoS One

41. HAMILL MM, Onzia A, Parkes-Ratanshi RM, Kyambadde P, et al
    Antibiotic overuse, poor antimicrobial stewardship, and low specificity of syndromic case management in a cross section of men with urethral discharge syndrome in Kampala, Uganda.
    PLoS One. 2024;19:e0290574.
    

    >> Share

    
    
42. CHIRESHE R, Manyangadze T, Naidoo K
    Integrated chronic care models for people with comorbid of HIV and non-communicable diseases in Sub-Saharan Africa: A scoping review.
    PLoS One. 2024;19:e0299904.
    

    >> Share

    
    
43. BOGALE EK, Zewdie A, Kassie TD, Anagaw TF, et al
    Suicidal ideation, attempt, and its associated factors among adult HIV/AIDS patients in Ethiopia: A systematic review and meta-analysis study.
    PLoS One. 2024;19:e0294078.
    

    >> Share

    
    
44. DEVLIN SA, Johnson AK, Stanford KA, Haider S, et al
    "There hasn't been a push to identify patients in the emergency department"-Staff perspectives on automated identification of candidates for pre-exposure prophylaxis (PrEP): A qualitative study.
    PLoS One. 2024;19:e0300540.
    

    >> Share

    
    
45. ELSAYED B, Elmarasi M, Madzime RJ, Mapahla L, et al
    Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010-2023-A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298387.
    

    >> Share

    
    
46. ABRAHA HE, Teka H, Legesse AY, Ebrahim MM, et al
    Causes of death among women of reproductive age during the war in Tigray, Ethiopia.
    PLoS One. 2024;19:e0299650.
    

    >> Share

    
    
47. CUNHA R, Filho DBM, M Albuquerque MFP, Lacerda HR, et al
    The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
    PLoS One. 2024;19:e0299244.
    

    >> Share

    
    
48. AIZIRE J, Yende-Zuma N, Hanley S, Nematadzira T, et al
    Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort.
    PLoS One. 2024;19:e0290285.
    

    >> Share

    
    
49. GALLAGHER KE, Awori JO, Knoll MD, Rhodes J, et al
    Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.
    PLoS One. 2024;19:e0297159.
    

    >> Share

    
    
50. KAUMBA PC, Siameka D, Kagujje M, Chungu C, et al
    Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.
    PLoS One. 2024;19:e0287876.
    

    >> Share

    
    

    
    PLoS Pathog

51. ZHANG X, Hu Y, Vandenhoudt RE, Yan C, et al
    Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts.
    PLoS Pathog. 2024;20:e1012063.
    

    >> Share

    
    

    
    Science

52. COHEN J
    'I'm not Tony': Anthony Fauci's heir vows new direction at NIAID.
    Science. 2024;383:1168-1169.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share